CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Minami, K.
Right arrow Articles by Shigematsu, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Minami, K.
Right arrow Articles by Shigematsu, A.
Canadian Journal of Anesthesia 51:545-548 (2004)
© Canadian Anesthesiologists' Society, 2004

General Anesthesia

Intramuscular tramadol increases gastric pH during anesthesia

[L’administration intramusculaire du tramadol augmente le pH gastrique pendant l’anesthésie]

Kouichiro Minami, MD PhD, Junichi Ogata, MD PhD, Takafumi Horishita, MD PhD, Munehiro Shiraishi, MD, Takashi Okamoto, MD, Takeyoshi Sata, MD PhD and Akio Shigematsu, MD PhD

From the Department of Anesthesiology, School of Medicine, University of Occupational and Environmental Health, Yahatanishiku, Kitakyushu, Japan.

Address correspondence to: Dr. Kouichiro Minami, Department of Anesthesiology, School of Medicine, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishiku, Kitakyushu 807-8555, Japan. Phone: +81-93-691-7265; Fax: +81-93-601-2910; E-mail: kminami{at}med.uoeh-u.ac.jp

Purpose: Tramadol, [(1RS, 2RS)-2-dimethylamino) methyl-1-(3-methoxyphenyl)-cyclohexanol hydrochloride], is an analgesic in clinical use. It has been reported that tramadol inhibits muscarinic type 3 receptor function, which primarily mediates smooth muscle contraction and glandular secretion. We investigated the effects of tramadol on the pH of gastric juices during anesthesia to determine whether tramadol inhibits secretion from the gastric glands.

Methods: ASA physical status I or II adult patients (n = 30) presenting for major elective orthopedic surgery of the upper extremities or mastectomy were enrolled. Patients were randomly assigned to receive treatment with tramadol (n = 10), famotidine (n = 10), or saline (n = 10). General anesthesia was then induced using propofol, vecuronium bromide, and fentanyl. After inducing anesthesia, the gastric pH was measured using pH test paper and, then, 100 mg tramadol, 20 mg famotidine, or saline were injected into the deltoid muscle. Three hours after starting the operation, gastric juice was again aspirated and its gastric pH measured.

Results: There were no differences in the pH before anesthesia between the three groups. By contrast, gastric pH was increased in the tramadol group by the same amount as it was in the famotidine group three hours after administering the drugs. Gastric pH of the saline, famotidine, and tramadol groups was 2.6 ± 2.5, 6.3 ± 2.0, and 6.4 ± 0.8, respectively.

Conclusion: These results suggest that tramadol inhibits the secretion of gastric acid.




This article has been cited by other articles:


Home page
Br J AnaesthHome page
M. Elhakim, W. A. El-Megid, A. Metry, A. El-hennawy, and K. El-Queseny
Analgesic and antacid properties of i.m. tramadol given before Caesarean section under general anaesthesia
Br. J. Anaesth., December 1, 2005; 95(6): 811 - 815.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Canadian Anesthesiologists' Society.